Results: 1-25 | 26-50 | 51-75 | 76-82
Results: 1-25/82

Authors: DeVita, VT Hellman, S Rosenberg, SA
Citation: Vt. Devita et al., Untitled, CANCER J, 7(2), 2001, pp. 85-85

Authors: DeVita, VT Hellman, S Rosenberg, SA
Citation: Vt. Devita et al., Special issue: Focus on molecular medicine - From the editors, CANCER J, 7(1), 2001, pp. 1-1

Authors: DeVita, VT Hellman, S Rosenberg, SA
Citation: Vt. Devita et al., Untitled, CANCER J, 7, 2001, pp. S1-S1

Authors: Mocellin, S Fetsch, T Abati, T Phan, GQ Wang, J Provenzano, M Stroncek, D Rosenberg, SA Marincola, FM
Citation: S. Mocellin et al., Laser scanning cytometry evaluation of MART-1, gp100, and HLA-A2 expression in melanoma metastases, J IMMUNOTH, 24(6), 2001, pp. 447-458

Authors: Harada, M Li, YF El-Gamil, M Ohnmacht, GA Rosenberg, SA Robbins, PF
Citation: M. Harada et al., Melanoma-reactive CD8(+) T cells recognize a novel tumor antigen expressedin a wide variety of tumor types, J IMMUNOTH, 24(4), 2001, pp. 323-333

Authors: Dudley, ME Wunderlich, J Nishimura, MI Yu, D Yang, JC Topalian, SL Schwartzentruber, DJ Hwu, P Marincola, FM Sherry, R Leitman, SF Rosenberg, SA
Citation: Me. Dudley et al., Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma, J IMMUNOTH, 24(4), 2001, pp. 363-373

Authors: Riley, JP Rosenberg, SA Parkhurst, MR
Citation: Jp. Riley et al., Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase, J IMMUNOTH, 24(3), 2001, pp. 212-220

Authors: Weiser, TS Guo, ZS Ohnmacht, GA Parkhurst, ML Tong-On, P Marincola, FM Fischette, MR Yu, XD Chen, GA Hong, JA Stewart, JH Nguyen, DM Rosenberg, SA Schrump, DS
Citation: Ts. Weiser et al., Sequential 5-aza-2 '-deoxycytidine-depsipeptide FR901228 treatment inducesapoptosis preferentially in cancer cells and facilitates their recognitionby cytolytic T lymphocytes specific for NY-ESO-1, J IMMUNOTH, 24(2), 2001, pp. 151-161

Authors: Ohnmacht, GA Phan, GQ Mavroukakis, SA Steinberg, SM Shea, YR Witebsky, FG McIntyre, LS Goodwin, RS Muehlbauer, PM Morton, KE Rogers-Freezer, LJ Seipp, CA Rosenberg, SA Marincola, FM
Citation: Ga. Ohnmacht et al., A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patientsreceiving high-dose intravenous interleukin-2, J IMMUNOTH, 24(2), 2001, pp. 188-192

Authors: Bownds, S Tong-On, P Rosenberg, SA Parkhurst, M
Citation: S. Bownds et al., Induction of tumor-reactive cytotoxic T-lymphocytes using a peptide from NY-ESO-1 modified at the carboxy-terminus to enhance HLA-A2.1 binding affinity and stability in solution, J IMMUNOTH, 24(1), 2001, pp. 1-9

Authors: Chang, E Rosenberg, SA
Citation: E. Chang et Sa. Rosenberg, Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy, J IMMUNOTH, 24(1), 2001, pp. 88-90

Authors: Rosenberg, SA
Citation: Sa. Rosenberg, Progress in the development of immunotherapy for the treatment of patientswith cancer, J INTERN M, 250(6), 2001, pp. 462-475

Authors: Phan, GQ Attia, P Steinberg, SM White, DE Rosenberg, SA
Citation: Gq. Phan et al., Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma, J CL ONCOL, 19(15), 2001, pp. 3477-3482

Authors: Rosenberg, SA
Citation: Sa. Rosenberg, Progress in human tumour immunology and immunotherapy, NATURE, 411(6835), 2001, pp. 380-384

Authors: Zeng, G Wang, X Robbins, PF Rosenberg, SA Wang, RF
Citation: G. Zeng et al., CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production, P NAS US, 98(7), 2001, pp. 3964-3969

Authors: Vasselli, JR Yang, JC Linehan, WM White, DE Rosenberg, SA Walther, MM
Citation: Jr. Vasselli et al., Lack of retroperitoneal lymphadenopathy predicts survival of patients withmetastatic renal cell carcinoma, J UROL, 166(1), 2001, pp. 68-72

Authors: Ohnmacht, GA Wang, E Mocellin, S Abati, A Filie, A Fetsch, P Riker, AI Kammula, US Rosenberg, SA Marincola, FM
Citation: Ga. Ohnmacht et al., Short-term kinetics of tumor antigen expression in response to vaccination, J IMMUNOL, 167(3), 2001, pp. 1809-1820

Authors: Liu, K Rosenberg, SA
Citation: K. Liu et Sa. Rosenberg, Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity, J IMMUNOL, 167(11), 2001, pp. 6356-6365

Authors: Monsurro, V Nielsen, MB Perez-Diez, A Dudley, ME Wang, E Rosenberg, SA Marincola, FM
Citation: V. Monsurro et al., Kinetics of TCR use in response to repeated epitope-specific immunization, J IMMUNOL, 166(9), 2001, pp. 5817-5825

Authors: Kawakami, Y Wang, X Shofuda, T Sumimoto, H Tupesis, JP Fitzgerald, E Rosenberg, SA
Citation: Y. Kawakami et al., Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes, J IMMUNOL, 166(4), 2001, pp. 2871-2877

Authors: Harada, M Li, YF El-Gamil, M Rosenberg, SA Robbins, PF
Citation: M. Harada et al., Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A0201-restricted T cells, CANCER RES, 61(3), 2001, pp. 1089-1094

Authors: Touloukian, CE Leitner, WW Robbins, PF Rosenberg, SA Restifo, NP
Citation: Ce. Touloukian et al., Mining the melanosome for tumor vaccine targets: P. polypeptide is a noveltumor-associated, CANCER RES, 61(22), 2001, pp. 8100-8104

Authors: Horning, SJ Negrin, RS Hoppe, RT Rosenberg, SA Chao, NJ Long, GD Brown, BW Blume, KG
Citation: Sj. Horning et al., High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial, BLOOD, 97(2), 2001, pp. 404-409

Authors: Kammula, US Marincola, FM Rosenberg, SA
Citation: Us. Kammula et al., Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination, J NAT CANC, 92(16), 2000, pp. 1336-1344

Authors: DeVita, VT Hellman, S Rosenberg, SA
Citation: Vt. Devita et al., From the editors, CANCER J, 6(4), 2000, pp. 191-191
Risultati: 1-25 | 26-50 | 51-75 | 76-82